519 related articles for article (PubMed ID: 11485629)
1. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
[TBL] [Abstract][Full Text] [Related]
2. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium.
Perricone MA; Morris JE; Pavelka K; Plog MS; O'Sullivan BP; Joseph PM; Dorkin H; Lapey A; Balfour R; Meeker DP; Smith AE; Wadsworth SC; St George JA
Hum Gene Ther; 2001 Jul; 12(11):1383-94. PubMed ID: 11485630
[TBL] [Abstract][Full Text] [Related]
3. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A
C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273
[TBL] [Abstract][Full Text] [Related]
4. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.
Knowles MR; Hohneker KW; Zhou Z; Olsen JC; Noah TL; Hu PC; Leigh MW; Engelhardt JF; Edwards LJ; Jones KR
N Engl J Med; 1995 Sep; 333(13):823-31. PubMed ID: 7544439
[TBL] [Abstract][Full Text] [Related]
5. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis.
Crystal RG; McElvaney NG; Rosenfeld MA; Chu CS; Mastrangeli A; Hay JG; Brody SL; Jaffe HA; Eissa NT; Danel C
Nat Genet; 1994 Sep; 8(1):42-51. PubMed ID: 7527271
[TBL] [Abstract][Full Text] [Related]
6. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector.
Hay JG; McElvaney NG; Herena J; Crystal RG
Hum Gene Ther; 1995 Nov; 6(11):1487-96. PubMed ID: 8573621
[TBL] [Abstract][Full Text] [Related]
7. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis.
Zuckerman JB; Robinson CB; McCoy KS; Shell R; Sferra TJ; Chirmule N; Magosin SA; Propert KJ; Brown-Parr EC; Hughes JV; Tazelaar J; Baker C; Goldman MJ; Wilson JM
Hum Gene Ther; 1999 Dec; 10(18):2973-85. PubMed ID: 10609658
[TBL] [Abstract][Full Text] [Related]
8. Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial.
Moss RB; Rodman D; Spencer LT; Aitken ML; Zeitlin PL; Waltz D; Milla C; Brody AS; Clancy JP; Ramsey B; Hamblett N; Heald AE
Chest; 2004 Feb; 125(2):509-21. PubMed ID: 14769732
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
[TBL] [Abstract][Full Text] [Related]
10. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
[TBL] [Abstract][Full Text] [Related]
11. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus.
Harvey BG; Leopold PL; Hackett NR; Grasso TM; Williams PM; Tucker AL; Kaner RJ; Ferris B; Gonda I; Sweeney TD; Ramalingam R; Kovesdi I; Shak S; Crystal RG
J Clin Invest; 1999 Nov; 104(9):1245-55. PubMed ID: 10545523
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.
Flotte TR; Zeitlin PL; Reynolds TC; Heald AE; Pedersen P; Beck S; Conrad CK; Brass-Ernst L; Humphries M; Sullivan K; Wetzel R; Taylor G; Carter BJ; Guggino WB
Hum Gene Ther; 2003 Jul; 14(11):1079-88. PubMed ID: 12885347
[TBL] [Abstract][Full Text] [Related]
13. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA
J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884
[TBL] [Abstract][Full Text] [Related]
14. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis.
Hyde SC; Southern KW; Gileadi U; Fitzjohn EM; Mofford KA; Waddell BE; Gooi HC; Goddard CA; Hannavy K; Smyth SE; Egan JJ; Sorgi FL; Huang L; Cuthbert AW; Evans MJ; Colledge WH; Higgins CF; Webb AK; Gill DR
Gene Ther; 2000 Jul; 7(13):1156-65. PubMed ID: 10918483
[TBL] [Abstract][Full Text] [Related]
15. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung.
Conrad CK; Allen SS; Afione SA; Reynolds TC; Beck SE; Fee-Maki M; Barrazza-Ortiz X; Adams R; Askin FB; Carter BJ; Guggino WB; Flotte TR
Gene Ther; 1996 Aug; 3(8):658-68. PubMed ID: 8854091
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo controlled, dose ranging study to evaluate the safety and biological efficacy of the lipid-DNA complex GR213487B in the nasal epithelium of adult patients with cystic fibrosis.
Knowles MR; Noone PG; Hohneker K; Johnson LG; Boucher RC; Efthimiou J; Crawford C; Brown R; Schwartzbach C; Pearlman R
Hum Gene Ther; 1998 Jan; 9(2):249-69. PubMed ID: 9472784
[TBL] [Abstract][Full Text] [Related]
17. Radioisotopic imaging allows optimization of adenovirus lung deposition for cystic fibrosis gene therapy.
Lerondel S; Le Pape A; Sené C; Faure L; Bernard S; Diot P; Nicolis E; Mehtali M; Lusky M; Cabrini G; Pavirani A
Hum Gene Ther; 2001 Jan; 12(1):1-11. PubMed ID: 11177537
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA.
Rosenfeld MA; Chu CS; Seth P; Danel C; Banks T; Yoneyama K; Yoshimura K; Crystal RG
Hum Gene Ther; 1994 Mar; 5(3):331-42. PubMed ID: 7517189
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated generation of cAMP-stimulated Cl- transport in cystic fibrosis airway epithelia in vitro: effect of promoter and administration method.
Zabner J; Wadsworth SC; Smith AE; Welsh MJ
Gene Ther; 1996 May; 3(5):458-65. PubMed ID: 9156806
[TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung.
Yei S; Mittereder N; Wert S; Whitsett JA; Wilmott RW; Trapnell BC
Hum Gene Ther; 1994 Jun; 5(6):731-44. PubMed ID: 7948135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
